Alterity Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.196x

Alterity Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, Alterity Therapeutics Ltd (ATH) has a cash flow conversion efficiency ratio of -0.196x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-10.62 Million ≈ $-7.51 Million USD) by net assets (AU$54.27 Million ≈ $38.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alterity Therapeutics Ltd (2002–2025)

Cash flow conversion efficiency of Alterity Therapeutics Ltd from 2002 to 2025. This chart illustrates how Alterity Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Alterity Therapeutics Ltd for real-time trading data and today's change.

Alterity Therapeutics Ltd Cash Flow Conversion Ratio Explained

Alterity Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alterity Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alterity Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see Alterity Therapeutics Ltd (ATH) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Boldt S.A BA:BOLT	0.157x
VIROMED MEDICAL NA O.N. XETRA:VME	N/A
WiSoL CO.LTD KQ:122990	0.024x
Idsud S.A PA:ALIDS	-0.907x
La Française de l'Energie S.A. PA:FDE	0.040x
Riber S.A PA:ALRIB	-0.100x
Balwin Properties Ltd JSE:BWN	0.029x
Falco Resources Ltd V:FPC	-0.005x

Annual Cash Flow Conversion Efficiency for Alterity Therapeutics Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Alterity Therapeutics Ltd from 2002 to 2025. Review cash generation quality of Alterity Therapeutics Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$42.40 Million ≈ $30.00 Million	AU$-11.45 Million ≈ $-8.10 Million	-0.270x	+70.44%
2024-06-30	AU$13.80 Million ≈ $9.76 Million	AU$-12.61 Million ≈ $-8.92 Million	-0.914x	-4.02%
2023-06-30	AU$22.81 Million ≈ $16.14 Million	AU$-20.04 Million ≈ $-14.18 Million	-0.878x	-152.49%
2022-06-30	AU$35.47 Million ≈ $25.10 Million	AU$-12.34 Million ≈ $-8.73 Million	-0.348x	+38.84%
2021-06-30	AU$30.47 Million ≈ $21.56 Million	AU$-17.33 Million ≈ $-12.26 Million	-0.569x	+36.39%
2020-06-30	AU$10.55 Million ≈ $7.46 Million	AU$-9.43 Million ≈ $-6.67 Million	-0.894x	-6.07%
2019-06-30	AU$16.55 Million ≈ $11.71 Million	AU$-13.95 Million ≈ $-9.87 Million	-0.843x	-117.06%
2018-06-30	AU$16.08 Million ≈ $11.38 Million	AU$-6.25 Million ≈ $-4.42 Million	-0.388x	-56.86%
2017-06-30	AU$23.69 Million ≈ $16.76 Million	AU$-5.87 Million ≈ $-4.15 Million	-0.248x	-4.68%
2016-06-30	AU$31.37 Million ≈ $22.19 Million	AU$-7.42 Million ≈ $-5.25 Million	-0.237x	+14.91%
2015-06-30	AU$39.11 Million ≈ $27.68 Million	AU$-10.87 Million ≈ $-7.69 Million	-0.278x	+24.04%
2014-06-30	AU$37.69 Million ≈ $26.67 Million	AU$-13.79 Million ≈ $-9.76 Million	-0.366x	+35.69%
2013-06-30	AU$13.97 Million ≈ $9.89 Million	AU$-7.95 Million ≈ $-5.63 Million	-0.569x	+53.26%
2012-06-30	AU$5.62 Million ≈ $3.98 Million	AU$-6.85 Million ≈ $-4.84 Million	-1.217x	-85.11%
2011-06-30	AU$6.93 Million ≈ $4.90 Million	AU$-4.56 Million ≈ $-3.23 Million	-0.658x	+26.97%
2010-06-30	AU$5.23 Million ≈ $3.70 Million	AU$-4.71 Million ≈ $-3.33 Million	-0.900x	+51.72%
2009-06-30	AU$3.75 Million ≈ $2.65 Million	AU$-6.99 Million ≈ $-4.95 Million	-1.865x	-95.95%
2008-06-30	AU$9.89 Million ≈ $7.00 Million	AU$-9.41 Million ≈ $-6.66 Million	-0.952x	+41.93%
2007-06-30	AU$5.61 Million ≈ $3.97 Million	AU$-9.20 Million ≈ $-6.51 Million	-1.639x	-22.82%
2006-06-30	AU$8.73 Million ≈ $6.18 Million	AU$-11.66 Million ≈ $-8.25 Million	-1.335x	-129.03%
2005-06-30	AU$19.51 Million ≈ $13.81 Million	AU$-11.37 Million ≈ $-8.05 Million	-0.583x	-321.78%
2004-06-30	AU$38.47 Million ≈ $27.22 Million	AU$-5.31 Million ≈ $-3.76 Million	-0.138x	+39.11%
2003-06-30	AU$15.78 Million ≈ $11.16 Million	AU$-3.58 Million ≈ $-2.53 Million	-0.227x	-0.44%
2002-06-30	AU$16.68 Million ≈ $11.80 Million	AU$-3.77 Million ≈ $-2.67 Million	-0.226x	--

About Alterity Therapeutics Ltd

AU:ATH Australia Biotechnology

Market Cap

$2.04 Billion

AU$2.88 Billion AUD

Market Cap Rank

#18617 Global

#579 in Australia

Share Price

AU$0.27

Change (1 day)

-7.02%

52-Week Range

AU$0.01 - AU$0.71

All Time High

AU$0.71